M3 (MTHRY) Moat Score: 6/10 (As of Jun. 27, 2026)


MTHRY M3 Inc MTHRY
86 GF Score
Price $5.45
GF Value $7.68
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is M3 Moat Score?

M3 MTHRY +2.83% 86 Moat Score is 6 as of Jun. 27, 2026. GuruFocus rates MTHRY with a GF Score™ of 86/100 and a GF Value™ of $7.68 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 681 Healthcare Providers & Services companies, M3 ranks better than 99.12% on this metric.

M3 has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

M3 has Narrow Moat: M3 Inc benefits from strong brand strength, significant customer loyalty, and valuable intellectual property in the healthcare information sector. These factors contribute to a strong narrow moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes M3 might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

M3  (OTCPK:MTHRY) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

M3 Moat Score Related Terms

MTHRY vs VEEV, BTSG, TEM: Moat Score Comparison

For the Health Information Services subindustry, M3's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

M3 Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M3's Moat Score distribution charts can be found below:

* The bar in red indicates where M3's Moat Score falls into.


MTHRY
86GF Score
M3 Inc MTHRY
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
M3 (MTHRY) has a Moat Score of 6 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, M3 ranks #6 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 0.90000000000001%.
Is M3's Moat Score too high?
M3's current Moat Score is 6. Based on the distribution chart, M3 ranks #6 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, M3 has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's Moat Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, M3 ranks #6 out of 681 companies for Moat Score. This places M3 in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. M3's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.68, compared to a current price of $5.45 — trading 29% below its estimated fair value. The current Moat Score is 6. M3's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For M3 (MTHRY), the current Moat Score is 6 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M3 (MTHRY) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of $5.45 is trading 29% below its estimated GF Value™ of $7.68. GuruFocus considers M3 to be Modestly Undervalued.

Key valuation signals for MTHRY:

  • Moat Score: 6
  • GF Value™: $7.68 vs. price of $5.45 (29% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M3 Business Description

Other Exchanges 2413:Japan4YC:Germany
Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
86GF Score

Get the complete analysis for MTHRY

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.45
Price
$7.68
GF Value